Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Sweatt

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Pulmonary Circulation|March 4, 2025
Developing Benchmarks in the Diagnosis and Treatment of Pulmonary Arterial Hypertension in a Tertiary, Academic Medical CenterCyrus A Kholdani, Justin H Lee, Kai E Swenson, et al.
American Journal of Respiratory and Critical Care Medicine|September 22, 2017
Features and Outcomes of Methamphetamine-associated Pulmonary Arterial HypertensionRoham T Zamanian, Haley Hedlin, Paul Greuenwald, et al.
Chest|June 28, 2021
Severe Pulmonary Arterial Hypertension Is Characterized by Increased Neutrophil Elastase and Relative Elafin DeficiencyAndrew J Sweatt, Kazuya Miyagawa, Christopher J Rhodes, et al.
American Journal of Respiratory and Critical Care Medicine|March 2, 2021
Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled TrialRoham T Zamanian, David Badesch, Lorinda Chung, et al.
Chest|August 25, 2024
Association of Phosphodiesterase-5 Inhibitor Treatment With Improved Survival in Pulmonary Hypertension Associated With COPD in the Pulmonary Vascular Research Institute GoDeep Meta-RegistryKhodr Tello, Athiththan Yogeswaran, Raphael W Majeed, et al.
American Journal of Respiratory and Critical Care Medicine|June 13, 2022
Endogenous Retroviral Elements Generate Pathologic Neutrophils in Pulmonary Arterial HypertensionShalina Taylor, Sarasa Isobe, Aiqin Cao, et al.
Pulmonary Circulation|July 10, 2025
Survival Outcomes and Impact of Targeted PAH Therapy in Portopulmonary Hypertension in the PVRI GoDeep Meta-RegistryArun Jose, Athiththan Yogeswaran, Meike Fuenderich, et al.
American Journal of Respiratory and Critical Care Medicine|January 10, 2020
Genetic Admixture and Survival in Diverse Populations with Pulmonary Arterial HypertensionJason H Karnes, Howard W Wiener, Tae-Hwi Schwantes-An, et al.
Journal of the American College of Cardiology|April 23, 2021
NHLBI-CMREF Workshop Report on Pulmonary Vascular Disease Classification: JACC State-of-the-Art ReviewWilliam M Oldham, Anna R Hemnes, Micheala A Aldred, et al.
Chest|March 20, 2024
Comparison of Contemporary Risk Scores in All Groups of Pulmonary Hypertension: A Pulmonary Vascular Research Institute GoDeep Meta-Registry AnalysisAthiththan Yogeswaran, Henning Gall, Meike Fünderich, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Pulmonary Circulation|March 4, 2025
Developing Benchmarks in the Diagnosis and Treatment of Pulmonary Arterial Hypertension in a Tertiary, Academic Medical CenterCyrus A Kholdani, Justin H Lee, Kai E Swenson, et al.
American Journal of Respiratory and Critical Care Medicine|September 22, 2017
Features and Outcomes of Methamphetamine-associated Pulmonary Arterial HypertensionRoham T Zamanian, Haley Hedlin, Paul Greuenwald, et al.
Chest|June 28, 2021
Severe Pulmonary Arterial Hypertension Is Characterized by Increased Neutrophil Elastase and Relative Elafin DeficiencyAndrew J Sweatt, Kazuya Miyagawa, Christopher J Rhodes, et al.
American Journal of Respiratory and Critical Care Medicine|March 2, 2021
Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled TrialRoham T Zamanian, David Badesch, Lorinda Chung, et al.
Chest|August 25, 2024
Association of Phosphodiesterase-5 Inhibitor Treatment With Improved Survival in Pulmonary Hypertension Associated With COPD in the Pulmonary Vascular Research Institute GoDeep Meta-RegistryKhodr Tello, Athiththan Yogeswaran, Raphael W Majeed, et al.
American Journal of Respiratory and Critical Care Medicine|June 13, 2022
Endogenous Retroviral Elements Generate Pathologic Neutrophils in Pulmonary Arterial HypertensionShalina Taylor, Sarasa Isobe, Aiqin Cao, et al.
Pulmonary Circulation|July 10, 2025
Survival Outcomes and Impact of Targeted PAH Therapy in Portopulmonary Hypertension in the PVRI GoDeep Meta-RegistryArun Jose, Athiththan Yogeswaran, Meike Fuenderich, et al.
American Journal of Respiratory and Critical Care Medicine|January 10, 2020
Genetic Admixture and Survival in Diverse Populations with Pulmonary Arterial HypertensionJason H Karnes, Howard W Wiener, Tae-Hwi Schwantes-An, et al.
Journal of the American College of Cardiology|April 23, 2021
NHLBI-CMREF Workshop Report on Pulmonary Vascular Disease Classification: JACC State-of-the-Art ReviewWilliam M Oldham, Anna R Hemnes, Micheala A Aldred, et al.
Chest|March 20, 2024
Comparison of Contemporary Risk Scores in All Groups of Pulmonary Hypertension: A Pulmonary Vascular Research Institute GoDeep Meta-Registry AnalysisAthiththan Yogeswaran, Henning Gall, Meike Fünderich, et al.
Pageof 6